Section Arrow
TENX.NASDAQ
- Tenax Therapeutics
Quotes are at least 15-min delayed:2026/01/07 23:18 EST
Regular Hours
Last
 12.85
-0.42 (-3.17%)
Day High 
14.015 
Prev. Close
13.27 
1-M High
14.22 
Volume 
332.00K 
Bid
12.87
Ask
13.2
Day Low
12.4 
Open
13.4 
1-M Low
9.4 
Market Cap 
82.85M 
Currency 美元 
P/E 3.28 
%Yield -- 
10-SMA 12.27 
20-SMA 11.62 
50-SMA 9.37 
52-W High 14.22 
52-W Low 4.63 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.74/-1.47
Enterprise Value
82.85M
Balance Sheet
Book Value Per Share
15.41
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1256+0.0206+19.62%-- 
ERASErasca5.17+1.54+42.42%-- 
RXRXRecursion Pharmaceuticals4.86+0.31+6.81%-- 
VTYXVentyx Biosciences13.73+3.68+36.62%-- 
GLUEMonte Rosa Therapeutics23.28+7.27+45.41%54.09PE
Industry overview quotes are at least 15 minutes delayed
Business Description
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North Americanrights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved EjectionFraction.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.